The green signal to the drug, Balversa, makes it the first approved treatment for bladder cancer that targets a genetic alteration known as FGFR3 or FGFR2, the FDA said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US FDA approves GSK's two-drug HIV treatmentThe U.S. Food and Drug Administration said on Monday it had approved GlaxoSmithKline Plc's two-drug HIV treatment.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US FDA refuses to review Zogenix's seizure treatmentREUTERS: The U.S. Food and Drug Administration on Monday refused to review the marketing application for Zogenix Inc's treatment for seizures ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US charges 24 in telemedicine healthcare fraud causing US$1.2 billion lossesREUTERS: U.S. authorities on Tuesday said 24 defendants have been charged in connection with one of the largest health care fraud schemes ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »